Impaired insulin signalling and allostatic load in Alzheimer disease

FG De Felice, RA Gonçalves, ST Ferreira - Nature Reviews …, 2022 - nature.com
The discovery of insulin in 1921 revolutionized the treatment of diabetes and paved the way
for numerous studies on hormone signalling networks and actions in peripheral tissues and …

[HTML][HTML] Interaction between Aβ and tau in the pathogenesis of Alzheimer's disease

H Zhang, W Wei, M Zhao, L Ma, X Jiang… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Extracellular neuritic plaques composed of amyloid‑β (Aβ) protein and intracellular
neurofibrillary tangles containing phosphorylated tau protein are the two hallmark proteins of …

The role of PI3K/Akt and ERK in neurodegenerative disorders

SN Rai, H Dilnashin, H Birla, SS Singh, W Zahra… - Neurotoxicity …, 2019 - Springer
Abstract Disruption of Akt and Erk-mediated signal transduction significantly contributes in
the pathogenesis of various neurodegenerative diseases (NDs), such as Parkinson's …

Epigallocatechin-3-Gallate (EGCG): New therapeutic perspectives for neuroprotection, aging, and neuroinflammation for the modern age

A Payne, S Nahashon, E Taka, GM Adinew… - Biomolecules, 2022 - mdpi.com
Alzheimer's and Parkinson's diseases are the two most common forms of neurodegenerative
diseases. The exact etiology of these disorders is not well known; however, environmental …

[HTML][HTML] Pathological roles of MAPK signaling pathways in human diseases

EK Kim, EJ Choi - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2010 - Elsevier
The mammalian family of mitogen-activated protein kinases (MAPKs) includes extracellular
signal-regulated kinase (ERK), p38, and c-Jun NH2-terminal kinase (JNK), with each MAPK …

Molecular mechanisms of neurodegeneration in Alzheimer's disease

L Crews, E Masliah - Human molecular genetics, 2010 - academic.oup.com
Alzheimer's disease (AD) is characterized by cognitive impairment, progressive
neurodegeneration and formation of amyloid-β (Aβ)-containing plaques and neurofibrillary …

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease–is this type 3 diabetes?

E Steen, BM Terry, E J. Rivera… - Journal of …, 2005 - journals.sagepub.com
The neurodegeneration that occurs in sporadic Alzheimer's disease (AD) is consistently
associated with a number of characteristic histopathological, molecular, and biochemical …

Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease

PJ Visser, LM Reus, J Gobom, I Jansen, E Dicks… - Molecular …, 2022 - Springer
Background Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of
Alzheimer's disease (AD) and is considered to result from neurodegeneration. T-tau levels …

Prediction of Alzheimer's disease using blood gene expression data

T Lee, H Lee - Scientific reports, 2020 - nature.com
Identification of AD (Alzheimer's disease)-related genes obtained from blood samples is
crucial for early AD diagnosis. We used three public datasets, ADNI, AddNeuroMed1 …

The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target

J Sun, G Nan - International journal of molecular …, 2017 - spandidos-publications.com
Signaling pathways are critical modulators of a variety of physiological and pathological
processes, and the abnormal activation of some signaling pathways can contribute to …